傳奇生物股票討論區

🗓️ Last week’s PDUFAs:
$Supernus Pharmaceuticals(SUPN.US)$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$傳奇生物(LEGN.US)$ & $強生(JNJ.US)$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$阿斯利康(AZN.US)$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US)$ & $施貴寶(BMY.US)$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$萬達生物製藥(VNDA.US)$...

$傳奇生物(LEGN.US)$
waiting patiently for fda 😌🙏✨

🗓️ Last week’s PDUFAs:
$Akebia Therapeutics(AKBA.US)$ : Approved 🎉
⇒ Vafseo (Vadadustat)
⇒ Anemia due to CKD
⇒ NDA
⇒ PDUFA: 3/27/24
$默沙東(MRK.US)$ : Approved 🎉
⇒ WINREVAIR (sotatercept)
⇒ Pulmonary arterial hypertension
⇒ BLA
⇒ PDUFA: 3/26/24
$阿斯利康(AZN.US)$ : Approved 🎉
⇒ Ultomiris (ravulizumab)
⇒ NMOSD
⇒ sBLA
$再生元製藥公司(REGN.US)$ : CRL 🙁
⇒ Odronextamab
⇒ r/r FL and r/r DLBCL
⇒ BLA
⇒ PDUFA: 3/31/24
📌 This week’s PDUFAs: 🚨
$阿斯利康(AZN.US)$ : 🤔
⇒...

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$萬達生物製藥(VNDA.US)$$傳奇生物(LEGN.US)$$Supernus Pharmaceuticals(SUPN.US)$$ImmunityBio(IBRX.US)$$Aquestive Therapeutics(AQST.US)$$X4製藥(XFOR.US)$$Liquidia(LQDA.US)$$神經分泌生物科學(NBIX.US)$$Moderna(MRNA.US)$$Day One Biopharmaceuticals(DAWN.US)$
...

$傳奇生物(LEGN.US)$$強生(JNJ.US)$
⇨ FDA’s briefing docs released today! 🔔
⚠️ Early deaths in cilta-cel arm raise FDA concern despite PFS benefit... 🤔
$LEGN trending up ~6% after doc release 📈
ℹ️ CARVYKTI (ciltacabtagene autoleucel)
⇒ multiple myeloma
⇒ CARTITUDE-4 study
⇒ sBLA
⇒ PDUFA: 4/5/24
❓AdCom Discussion & Question:
Discussion Topic:
⇒ Discuss whether the results of CARTITUDE-4 provided in the supplemental application are sufficient to support a positive...

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Eyenovia(EYEN.US)$$萬達生物製藥(VNDA.US)$$Mirum Pharmaceuticals(MIRM.US)$$Madrigal Pharmaceuticals(MDGL.US)$$傑龍(GERN.US)$$施貴寶(BMY.US)$$2seventy bio(TSVT.US)$$傳奇生物(LEGN.US)$$OptiNose(OPTN.US)$$Orchard Therapeutics(ORTX.US)$$默沙東(MRK.US)$$Akebia Therapeutics(AKBA.US)$$阿斯利康(AZN.US)$$Liquidia(LQDA.US)$$Esperion Therapeutics(ESPR.US)$$再生元製藥公司(REGN.US)$$百濟神州(BGNE.US)$

A huge 3 day span will see 7 companies in front of the review board:
$Mirum Pharmaceuticals(MIRM.US)$
$Madrigal Pharmaceuticals(MDGL.US)$
$傑龍(GERN.US)$
$施貴寶(BMY.US)$
$傳奇生物(LEGN.US)$
$2seventy bio(TSVT.US)$
$OptiNose(OPTN.US)$

$傳奇生物(LEGN.US)$ what is going on here

$傳奇生物(LEGN.US)$
Will it still rise?